Literature DB >> 12496185

Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination.

Amminikutty Jeevan1, Teizo Yoshimura, Kyeong Eun Lee, David N McMurray.   

Abstract

To determine whether Mycobacterium bovis BCG vaccination would alter gamma interferon (IFN-gamma) mRNA expression in guinea pig cells exposed to Mycobacterium tuberculosis, we cloned a cDNA encoding guinea pig IFN-gamma from a spleen cell cDNA library. The cDNA is composed of 1,110 bp, with an open reading frame encoding a 166-amino-acid protein which shows 56 and 41% amino acid sequence homology to human and mouse IFN-gamma, respectively. Spleen or lymph node cells from naïve and BCG-vaccinated guinea pigs were stimulated with purified protein derivative (PPD) or M. tuberculosis H37Ra or H37Rv, and the total RNA was subjected to Northern blot analysis with a (32)P-labeled probe derived from the cDNA clone. Compared to the IFN-gamma mRNA expression in cells of naïve animals, that in spleen and lymph node cells exposed to various stimuli was enhanced after BCG vaccination. However, there was a significant reduction in IFN-gamma mRNA levels when cells were stimulated with a multiplicity of infection of greater than 1 virulent M. tuberculosis bacterium per 10 cells. The enhanced IFN-gamma mRNA response in BCG-vaccinated animals was associated with an increase in the proportions of CD4(+) T cells in the spleens, as determined by fluorescence-activated cell sorter analysis. Furthermore, the nonadherent population in the spleens enriched either by panning with anti-guinea pig immunoglobulin G-coated plates or by purification on nylon wool columns produced more IFN-gamma mRNA than whole spleen cells following stimulation with concanavalin A or PPD. This indicates that T cells are principally responsible for the upregulation of IFN-gamma mRNA expression following BCG vaccination. The mechanism by which virulent mycobacteria suppress IFN-gamma mRNA accumulation is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496185      PMCID: PMC143318          DOI: 10.1128/IAI.71.1.354-364.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Differential release of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex.

Authors:  M B Michelini-Norris; D K Blanchard; C A Pearson; J Y Djeu
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

2.  Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy.

Authors:  T Söderblom; P Nyberg; A M Teppo; M Klockars; H Riska; T Pettersson
Journal:  Eur Respir J       Date:  1996-08       Impact factor: 16.671

3.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

4.  cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig.

Authors:  T Yoshimura; D G Johnson
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

5.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor.

Authors:  R Kamijo; D Shapiro; J Le; S Huang; M Aguet; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis.

Authors:  D S Robinson; S Ying; I K Taylor; A Wangoo; D M Mitchell; A B Kay; Q Hamid; R J Shaw
Journal:  Am J Respir Crit Care Med       Date:  1994-04       Impact factor: 21.405

8.  Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

Authors:  R Kamijo; J Le; D Shapiro; E A Havell; S Huang; M Aguet; M Bosland; J Vilcek
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  17 in total

1.  Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation.

Authors:  A Jeevan; C T McFarland; T Yoshimura; T Skwor; H Cho; T Lasco; D N McMurray
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.

Authors:  Peter A Gillis; Nelmary Hernandez-Alvarado; Josephine S Gnanandarajah; Felix Wussow; Don J Diamond; Mark R Schleiss
Journal:  Vaccine       Date:  2014-05-20       Impact factor: 3.641

3.  Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.

Authors:  Shihoko Komine-Aizawa; Toshio Yamazaki; Tsuyoshi Yamazaki; Shin-Ichiro Hattori; Yuji Miyamoto; Naoki Yamamoto; Shinji Haga; Masahiko Sugitani; Mitsuo Honda; Satoshi Hayakawa; Saburo Yamamoto
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

4.  Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.

Authors:  Ajay Grover; Jolynn Troudt; Kimberly Arnett; Linda Izzo; Megan Lucas; Katie Strain; Christine McFarland; Yper Hall; David McMurray; Ann Williams; Karen Dobos; Angelo Izzo
Journal:  Tuberculosis (Edinb)       Date:  2011-10-01       Impact factor: 3.131

5.  Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.

Authors:  Hyosun Cho; Todd M Lasco; Shannon Sedberry Allen; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.

Authors:  Julia A Tree; Michael J Elmore; Sajid Javed; Ann Williams; Philip D Marsh
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations.

Authors:  Todd M Lasco; Toshiko Yamamoto; Teizo Yoshimura; Shannon Sedberry Allen; Lynne Cassone; David N McMurray
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.

Authors:  A Jeevan; K Majorov; K Sawant; H Cho; D N McMurray
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

9.  Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Authors:  Ajay Grover; Jennifer Taylor; JoLynn Troudt; Andrew Keyser; Kimberly Arnett; Linda Izzo; Drew Rholl; Angelo Izzo
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

10.  Dietary polyunsaturated fatty acids modulate resistance to Mycobacterium tuberculosis in guinea pigs.

Authors:  Christine T McFarland; Yang-Yi Fan; Robert S Chapkin; Bradley R Weeks; David N McMurray
Journal:  J Nutr       Date:  2008-11       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.